Edition:
United Kingdom

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,658
52-wk High
$2.85
52-wk Low
$0.39

Latest Key Developments (Source: Significant Developments)

Akers Biosciences says Q3 revenue rose 10 pct to $675,800
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Akers Biosciences Inc -:Akers Biosciences announces Q3 2017 earnings.Q3 revenue rose 10 percent to $675,800.Akers Biosciences Inc - ‍Q3 gross margin reduced to 52%​.  Full Article

Akers Biosciences settles, to sell breath technology tests
Friday, 19 Aug 2016 

Akers Biosciences Inc : Settles dispute with Chube, Thirty Six Strategies Llc , Gavin Moran, Frank Runge - SEC Filing .Co can sell all of breath technology tests worldwide, unencumbered by past or future claims by Chube under licensing agreement.  Full Article

Akers Biosciences Q2 loss before income tax $1 million
Thursday, 11 Aug 2016 

Akers Biosciences Inc : Akers Biosciences announces h1 and q2 2016 earnings .Revenue for three months ended June 30, 2016 totaled $956,486, a 1% decrease from three months ended june 30, 2015..  Full Article

Akers Biosciences signs deal for Breathscan Oxichek(tm)
Monday, 27 Jun 2016 

Akers Biosciences Inc :Akers Biosciences signs distribution agreement for Breathscan Oxichek(tm).  Full Article

BRIEF-Akers Biosciences says Q3 revenue rose 10 pct to $675,800

* Akers Biosciences Inc - ‍Q3 gross margin reduced to 52%​ Source text for Eikon: Further company coverage: